PL4194437T3 - Związek trisiarczkowy - Google Patents
Związek trisiarczkowyInfo
- Publication number
- PL4194437T3 PL4194437T3 PL21861478.2T PL21861478T PL4194437T3 PL 4194437 T3 PL4194437 T3 PL 4194437T3 PL 21861478 T PL21861478 T PL 21861478T PL 4194437 T3 PL4194437 T3 PL 4194437T3
- Authority
- PL
- Poland
- Prior art keywords
- trisulfide compound
- trisulfide
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/41—Y being a hydrogen or an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
- C07C321/12—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms
- C07C321/14—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020143639 | 2020-08-27 | ||
| PCT/JP2021/030755 WO2022045052A1 (ja) | 2020-08-27 | 2021-08-23 | トリスルフィド化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4194437T3 true PL4194437T3 (pl) | 2026-02-02 |
Family
ID=80353266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21861478.2T PL4194437T3 (pl) | 2020-08-27 | 2021-08-23 | Związek trisiarczkowy |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12534432B2 (https=) |
| EP (1) | EP4194437B1 (https=) |
| JP (1) | JP7650279B2 (https=) |
| CN (1) | CN115943140B (https=) |
| ES (1) | ES3054285T3 (https=) |
| PL (1) | PL4194437T3 (https=) |
| WO (1) | WO2022045052A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7842033B2 (ja) | 2020-05-12 | 2026-04-07 | ザ ジェネラル ホスピタル コーポレイション | 神経保護におけるグルタチオントリスルフィド(gsssg) |
| EP4342464A4 (en) | 2021-07-08 | 2025-06-04 | Kyowa Pharma Chemical Co., Ltd. | PROPHYLACTIC OR THERAPEUTIC MEDICINE FOR PARKINSON'S DISEASE |
| EP4603087A1 (en) | 2022-11-21 | 2025-08-20 | Kyowa Hakko Bio Co., Ltd. | Prophylactic or therapeutic agent for acute kidney injury induced by anticancer agent |
| CN120344503A (zh) | 2022-12-27 | 2025-07-18 | 协和医药化工股份有限公司 | 三硫化物化合物 |
| WO2025070464A1 (ja) | 2023-09-28 | 2025-04-03 | 協和ファーマケミカル株式会社 | トリスルフィド化合物を含有する医薬組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS532931B2 (https=) * | 1973-12-05 | 1978-02-01 | ||
| JPS5819673B2 (ja) * | 1976-08-26 | 1983-04-19 | 相互薬工業株式会社 | パンテチンの製造方法 |
| JP2928414B2 (ja) | 1991-09-20 | 1999-08-03 | ポーラ化成工業株式会社 | 皮膚外用剤 |
| SE9402253D0 (sv) * | 1994-06-27 | 1994-06-27 | Pharmacia Ab | Process |
| CN107652264A (zh) | 2017-09-25 | 2018-02-02 | 苏州华诺医药有限公司 | 硫辛酸杂质a的制备方法 |
| JP2022074166A (ja) * | 2019-01-30 | 2022-05-18 | 協和発酵バイオ株式会社 | ポリスルフィド化合物を含有する組成物 |
| JP2022166333A (ja) * | 2019-09-18 | 2022-11-02 | 国立大学法人 熊本大学 | 活性イオウ分子種生体内濃度上昇剤 |
-
2021
- 2021-08-23 JP JP2022544576A patent/JP7650279B2/ja active Active
- 2021-08-23 ES ES21861478T patent/ES3054285T3/es active Active
- 2021-08-23 US US18/042,705 patent/US12534432B2/en active Active
- 2021-08-23 EP EP21861478.2A patent/EP4194437B1/en active Active
- 2021-08-23 PL PL21861478.2T patent/PL4194437T3/pl unknown
- 2021-08-23 WO PCT/JP2021/030755 patent/WO2022045052A1/ja not_active Ceased
- 2021-08-23 CN CN202180050867.6A patent/CN115943140B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7650279B2 (ja) | 2025-03-24 |
| WO2022045052A1 (ja) | 2022-03-03 |
| US20230357141A1 (en) | 2023-11-09 |
| ES3054285T3 (en) | 2026-02-02 |
| CN115943140A (zh) | 2023-04-07 |
| US12534432B2 (en) | 2026-01-27 |
| EP4194437B1 (en) | 2025-11-12 |
| EP4194437A1 (en) | 2023-06-14 |
| CN115943140B (zh) | 2024-10-01 |
| EP4194437A4 (en) | 2024-10-02 |
| JPWO2022045052A1 (https=) | 2022-03-03 |
| EP4194437C0 (en) | 2025-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB202019810D0 (en) | Compound | |
| IL304845A (en) | Pyrimidopyran compounds | |
| PL4194437T3 (pl) | Związek trisiarczkowy | |
| EP4452937A4 (en) | CONNECTIONS | |
| GB202216325D0 (en) | Compound | |
| GB202001564D0 (en) | Compounds | |
| GB202302314D0 (en) | Compound | |
| GB202301239D0 (en) | Compound | |
| GB202217858D0 (en) | Compound | |
| EP3981609A4 (en) | Trisulfide compound | |
| ES3063655T3 (en) | Compounds | |
| GB202208329D0 (en) | Compound | |
| GB202204673D0 (en) | Compound | |
| GB202117836D0 (en) | Compound | |
| GB202117834D0 (en) | Compound | |
| GB202018245D0 (en) | Compound | |
| GB202011787D0 (en) | Compound | |
| GB202010626D0 (en) | Compound | |
| GB202009074D0 (en) | Compound | |
| GB202318958D0 (en) | Compound | |
| GB202304745D0 (en) | Compound | |
| GB202304355D0 (en) | Compound | |
| GB202302315D0 (en) | Compound | |
| GB202217823D0 (en) | Compound | |
| GB202217854D0 (en) | Compound |